Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2995081

C1CCC(P(C2CCCCC2)C2CCCCC2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32
PDK3 Q15120 1/20 0.32
PDK4 Q16654 1/20 0.32
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
MLYCD O95822 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
EPHX1 P07099 5/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
MAPT P10636 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL27577008 1.00 CES2 (0.33) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL27556727 0.98 KEAP1 (0.31)
Trifluoroacetic Acid SCHEMBL1712787 0.86
Trifluoroacetic Acid SCHEMBL1451529 0.83 CES2 (0.31) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL3181588 0.83 CES2 (0.31) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL3181321 0.83 CES2 (0.31) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL3184978 0.83 CES2 (0.31) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL3165098 0.83 CES2 (0.31) CES2CES1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL3170584 0.80
Trifluoroacetic Acid SCHEMBL3175960 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501985-B2 Use of phosphonium salts in coupling reactions and process for their manufacture DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2013-08-06 US claimed
US-20100197969-A1 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2010-08-05 US claimed
WO-2009013628-A2 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) 2009-01-29 WO claimed
EP-2019107-A1 Use of phosphonium salts in coupling reactions and process for their manufacture Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 2009-01-28 EP claimed
CN-1208360-C In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes SUMITOMO BAKELITE CO (JP) 2005-06-29 CN claimed
CN-1554680-A In mold addition polymerization composition of norbornene-type monomers and its crosslinking addition polymer ס�ѵ�ľ��ʽ���� 2004-12-15 CN claimed
CN-1333788-A In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes GOODRICH CO B F (US) 2002-01-30 CN claimed
CN-1290275-A Catalyst and process for polymerization of cycloolefin GOODRICH CO B F (US) 2001-04-04 CN claimed
CN-120152955-A Compositions comprising isomer mixtures of itaconimide norbornene and citraconimide norbornene 3M创新有限公司 2025-06-13 CN disclosed
CN-117295752-A Monomers, polymerizable compositions, and polymers derived therefrom 3M创新有限公司 2023-12-26 CN disclosed
CN-116490538-A Curable composition, syntactic foam, method of preparing syntactic foam, and article comprising syntactic foam 3M创新有限公司 2023-07-25 CN disclosed
CN-107548405-B Chain transfer agent for addition bulk polymerization of polycycloolefinic monomers 住友电木株式会社 2018-12-14 CN disclosed
CN-106574008-B Polycyclic alkene block polymer and the osmotic evaporation film being produced from it 住友电木株式会社 2018-06-19 CN disclosed
CN-107548405-A Chain transfer agent for addition bulk polymerization of polycycloolefinic monomers 普罗米鲁斯有限责任公司 2018-01-05 CN disclosed
US-20030023013-A1 Catalyst and methods for polymerizing cycloolefins THE B.F.GOODRICH COMPANY 2003-01-30 US disclosed
US-20020052454-A1 CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS SUMITOMO BAKELITE CO., LTD. (JP) 2002-05-02 US disclosed
CN-1333788-A In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes GOODRICH CO B F (US) 2002-01-30 CN disclosed
CN-1290275-A Catalyst and process for polymerization of cycloolefin GOODRICH CO B F (US) 2001-04-04 CN disclosed
EP-1034196-A1 CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS THE B.F. GOODRICH COMPANY (US) 2000-09-13 EP disclosed
WO-2000020472-A1 CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS THE B.F. GOODRICH COMPANY (US) 2000-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197969-A1 USE OF PHOSPHONIUM SALTS IN COUPLING REACTIONS AND PROCESS FOR THEIR MANUFACTURE PPIP5K2, PHOSPHO1, PNKP CES2 3167/4885CES1 4223/4885PDK1 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.